Drugs & Targets Pan-Canadian Pharmaceutical Alliance, BMS reach agreement on Opdivo February 17, 2017Vol.43 No.07
Drugs & Targets Immunomedics enters into licensing agreement with Seattle Genetics for Sacituzumab Govitecan February 17, 2017Vol.43 No.07
In Brief U.S. Preventive Services Task Force appoints three new members February 17, 2017Vol.43 No.07
In Brief BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology February 17, 2017Vol.43 No.07
In Brief RPRD Diagnostics, Children’s Minnesota to advance clinical pharmacogenomics February 17, 2017Vol.43 No.07
